HOW BOYA10 WORKS — TARGETED ORAL MUCOSAL SUPPORT IN 3 + 1 STEPS
BOYA10 IS DESIGNED AS A CHEW–COAT–ABSORB NUTRACEUTICAL SYSTEM THAT DELIVERS PROTECTIVE ACTION FIRST INSIDE THE MOUTH (WHERE IRRITATION OCCURS), FOLLOWED BY CONTINUED WELLNESS SUPPORT AFTER SWALLOWING.
INSTEAD OF BYPASSING THE ORAL CAVITY LIKE CONVENTIONAL CAPSULES, BOYA10 IS FORMULATED TO REMAIN IN CONTACT WITH THE MUCOSAL LINING — ALLOWING THE BIOACTIVES TO ACT LOCALLY FIRST, SYSTEMICALLY SECOND.
STEP 1 — CHEWING & PHYTOTHERAPEUTIC RELEASE (0–1 MINUTE)
WHEN THE CAPSULE IS CHEWED, THE SHELL OPENS AND RELEASES A THICK, BIOACTIVE-RICH PROTECTIVE PASTE.
DURING THIS PHASE:
- THE BOWMAN–BIRK INHIBITOR AND EPIGALLOCATECHIN-3-GALLATE BEGIN INTERACTING WITH EPITHELIAL SURFACES
- PHOSPHATIDYLCHOLINE AND HPMC FORM A SOOTHING, LUBRICATING COATING
- ANTIOXIDANTS SUCH AS Α-TOCOPHEROL & BETA-CAROTENE BEGIN SURFACE NEUTRALISATION OF ROS
THIS IMMEDIATE EXPOSURE IS IMPORTANT BECAUSE THE ORAL MUCOSA IS THE FIRST TISSUE DAMAGED BY:
- SMOKING OR TOBACCO CHEWING
- ALCOHOL CONTACT
- CHRONIC HEAT EXPOSURE
- SPICY / ACIDIC / CHEMICAL IRRITANTS
THE INITIAL RELEASE PHASE HELPS SUPPORT:
- IRRITATION CALMING
- OXIDATIVE STRESS BUFFERING
- EPITHELIAL SURFACE PROTECTION
STEP 2 — ORAL COATING & MUCOSAL CONTACT (30 SEC.–1 MINUTE):
USING THE TONGUE, THE USER SPREADS THE PHYTOTHERAPEUTIC PASTE ACRO
- INNER CHEEKS
- GUMS
- TONGUE
- PALATE
- FLOOR OF MOUTH
BOYA10 FORMS A MUCOADHESIVE FILM-LIKE LAYER SUPPORTED BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), WHICH:
- IMPROVES RETENTION TIME ON MUCOSAL SURFACES
- ENHANCES UNIFORM DISTRIBUTION OF ACTIVES
- SUPPORTS MOISTURE BALANCE AND BARRIER COMFORT
THIS COATING PHASE ALLOWS KEY INGREDIENTS TO INTERACT DIRECTLY WITH VULNERABLE EPITHELIAL TISSUE, PARTICULARLY AREAS REPEATEDLY EXPOSED TO:
- HEAT
- CHEMICALS
- SMOKE TOXINS
- ALCOHOL IRRITANTS
THIS IS WHERE BOYA10 PROVIDES IT’S PRIMARY LOCAL-SUPPORTIVE FUNCTION.
STEP 3 — LOCAL ABSORPTION & CELLULAR DEFENCE(1-2 MINUTES):
DURING CONTACT TIME, THE BIOACTIVES PENETRATE THE SUPERFICIAL MUCOSAL LAYER AND SUPPORT:
- OXIDATIVE STRESS REDUCTION (EGCG, Α-TOCOPHEROL, CAROTENOIDS)
- INFLAMMATION MODULATION (DIFERULOYLMETHANE / CURCUMINOID ACTIVITY)
- EPITHELIAL BARRIER SUPPORT (PHOSPHATIDYLCHOLINE)
- CELLULAR DEFENCE SIGNALING (BOWMAN–BIRK INHIBITOR)
- EPITHELIAL DIFFERENTIATION & KERATIN REGULATION (RETINOIC ACID)
- DNA SYNTHESIS & MUCOSAL RENEWAL (PTEROYLGLUTAMIC ACID)
THIS LOCALIZED INTERACTION MATTERS BECAUSE THE ORAL MUCOSA:
- IS A HIGH-PERMEABILITY SURFACE
- CONTAINS DENSE CAPILLARY NETWORKS
- IS THE SITE OF DIRECT CHEMICAL EXPOSURE
BOYA10 IS DESIGNED TO SUPPORT:
- MUCOSAL RESILIENCE
- EPITHELIAL UNIFORMITY
- TISSUE COMFORT
- PROTECTIVE ANTIOXIDANT BALANCE
WHERE THE TISSUE NEEDS IT FIRST — INSIDE THE MOUTH.
STEP 4 — SWALLOWING & SYSTEMIC SUPPORT (POST-CONTACT PHASE)
AFTER COATING AND CONTACT TIME, THE REMAINING ACTIVES ARE SWALLOWED.
INSIDE THE GI TRACT, THE INGREDIENTS CONTINUE TO PROVIDE SECONDARY SYSTEMIC WELLNESS SUPPORT, INCLUDING:
- ANTIOXIDANT PROTECTION BEYOND THE ORAL CAVITY
- LIPID-MEMBRANE SUPPORT VIA PHOSPHATIDYLCHOLINE
- RETINOID-MEDIATED EPITHELIAL SUPPORT PATHWAYS
- FOLATE-MEDIATED CELLULAR REPAIR & DNA SYNTHESIS
- BROADER OXIDATIVE STRESS BUFFERING
THUS BOYA10 PROVIDES A DUAL-PHASE BENEFIT:
- LOCAL MUCOSAL SUPPORT DURING ORAL CONTACT
- SYSTEMIC ANTIOXIDANT & EPITHELIAL SUPPORT AFTER SWALLOWING
BOYA10 DELIVERY PHILOSOPHY:
CONVENTIONAL CAPSULES BYPASS THE ORAL CAVITY.
BOYA10 IS DIFFERENT — IT IS PURPOSE-DESIGNED TO:
- STAY IN THE MOUTH
- COAT EXPOSED TISSUES
- ACT AT THE SITE OF IRRITATION
- SUPPORT EPITHELIAL DEFENCE FIRST
FOLLOWED BY GENTLE SYSTEMIC WELLNESS SUPPORT.
CORE BENEFITS AT A GLANCE:
- HELPS KEEP THE ORAL LINING STRONG AND HEALTHY
- NEUTRALISES IRRITANTS FROM SMOKING/ ALCOHOL USE / TOBACCO CHEWING
- SUPPORTS HEALING OF MICRO-INJURIES INSIDE THE MOUTH
- HELPS REDUCE WHITE & RED MUCOSAL PATCHES (LEUKOPLAKIA – PRECANCEROUS LESION)
- MAINTAINS ORAL EPITHELIAL STRENGTH AND RESILIENCE
